ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Elderly"

  • Abstract Number: 56 • 2019 ACR/ARP Annual Meeting

    Choline Metabolite Is Associated with Inflammation in Arthritis in the Elderly

    francesca cedola1, Roxana Coras 2, Elsa Sanchez-Lopez 3, Lourdes Mateo 4, Anders Pedersen 5, Anahy Brandy-Garcia 4, Águeda Prior-Español 4, Brin S rosenthal 6, Melania Martínez-Morillo 4 and Monica Guma 7, 1University of California San Diego, Rome, Italy, 2. Department of Medicine, School of Medicine. University of California, San Diego, 3Department of Pharmacology, University of California San Diego, La Jolla, San Diego, 4Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 5University of Gothenburg, Gothenburg, Sweden, 6University of California San Diego, san diego, 7Department of Medicine, School of Medicine. University of California San Diego, La Jolla, United States

    Background/Purpose: Elderly-onset RA (EORA) and polymyalgia rheumatica (PMR) are common rheumatic disease in the elderly and their pathogenesis are still not completely understood. Perturbations caused…
  • Abstract Number: 325 • 2019 ACR/ARP Annual Meeting

    Frailty and Sarcopenia in Inflammatory Rheumatic Disease

    Elisa Trujillo1, Antonio Aznar 2, Hiurma Sanchez 1, Marta Hernandez 1, Alicia García 3 and Maria del mar Trujillo Martin 4, 1Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 2Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 3Hospital Universitario de Canarias, Santa cruz de Tenerife, 4Servicio de Evaluación y Planificación, Fundación Canaria de Investigación Sanitaria (FUNCANIS) Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC)., Santa Cruz de Tenerife, Spain

    Background/Purpose: Sarcopenia, the loss of skeletal muscle mass, is associated with adverse individual physical and metabolic changes contributing to morbidity and mortality. Sarcopenia is a…
  • Abstract Number: 1345 • 2019 ACR/ARP Annual Meeting

    Are There Differences in Efficacy and Safety of Biological Disease-modifying Antirheumatic Drugs Between Elderly-onset and Young-onset Rheumatoid Arthritis?

    Sadao Jinno1, Akira Onishi 2, Kengo Akashi 2, Motomu Hashimoto 3, Wataru Yamamoto 3, Koichi Murata 3, Tohru Takeuchi 4, Takuya Kotani 4, Yuichi Maeda 5, Kosuke Ebina 6, Yonsu Son 7, Hideki Amuro 7, Ryota Hara 8, Masanori Katayama 9, Jun Saegusa 2 and Akio Morinobu 2, 1Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Osaka, Japan, 2Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan, 3Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan, 4Department of Internal Medicine IV, Osaka Medical College, Osaka, Japan, 5Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan, 6Department of Musculoskeletal Regenerative Medicine, Osaka University, Graduate School of Medicine, Osaka, Japan, 7First Department of Internal Medicine, Kansai Medical University, Osaka, Japan, 8The Center for Rheumatic Disease, Department of Orthopedic Surgery, Nara Medical University, Nara, Japan, 9Department of Rheumatology, Osaka Red Cross Hospital, Osaka, Japan

    Background/Purpose: To compare efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) between elderly-onset rheumatoid arthritis (EORA) and young-onset rheumatoid arthritis (YORA) patients. Methods: Patients with…
  • Abstract Number: 2165 • 2019 ACR/ARP Annual Meeting

    Stakeholder Feedback on Novel Behavioral Intervention Targeting Comorbid Chronic Back Pain and Depression in Older Adults

    Ailing Yang1, Wei Yuet 2, LaDonna Saxon 3, James LePage 3, Liana Fraenkel 4, Manney Reid 5 and Una Makris 6, 1UT Southwestern Medical Center, Dallas, 2UNT Health Science Center, Fort Worth, 3Dallas VA Medical Center and UT Southwestern Medical Center, Dallas, 4Yale School of Medicine and VA Connecticut Healthcare System, New Haven, 5Weill Cornell Medicine, New York City, 6UT Southwestern Medical Center and Dallas VA Medical Center, Dallas

    Background/Purpose: Chronic low back pain (cLBP) is the 2nd most common reason for physician visits; annual related costs exceed $100 billion and are expected to…
  • Abstract Number: 2170 • 2019 ACR/ARP Annual Meeting

    Risk Factors for Poor Outcomes After Hip Fracture Patients in the Robust Elderly: Are Patient Reported Outcomes Important?

    Lisa Mandl1, Dina Sheira 2, Marianna Frey 3, Jackie Finik 2, Kirsten Grueter 3 and Joseph Lane 4, 1Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, New York, NY, 2Hospital for Special Surgery, New York, NY, New York, NY, 3Hospital for Special Surgery, New York, NY, New York, 4Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, New York

    Background/Purpose: Low energy hip fractures are feared harbingers of morbidity and mortality. However, many older adults are high functioning and cognitively intact at the time…
  • Abstract Number: 2392 • 2019 ACR/ARP Annual Meeting

    The Effectiveness of anti-IL-6 Therapy to Elderly-onset Rheumatoid Arthritis

    Takayasu Ando1, Takeshi Suzuki 2, Yutaka Gotou 1 and Kimito Kawahata 3, 1Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan, 2Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 3Rheumatology and Allergology, St. Marianna University School of Medicine, Tokyo, Japan

    Background/Purpose:  In daily practice, our rheumatologist has experienced different clinical feature of elderly-onset rheumatoid arthritis (EORA) compared with younger-onset RA (YORA). In EORA patients, serological…
  • Abstract Number: 417 • 2018 ACR/ARHP Annual Meeting

    Patient Reported Outcomes Pre and Post Intervention in Older Veterans with Chronic Back Pain

    Rabih Nayfe1, Matthieu Chansard2, Linda S. Hynan3, Eric M. Mortensen4 and Una E. Makris5, 1Department of Medicine, UT Southwestern Medical Center, Dallas, TX, 2Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, 3Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, 4UT Southwestern Medical Center, Dallas, TX, 5UT Southwestern Medical Center and Dallas VA, Dallas, TX

    Background/Purpose: Chronic back pain is the second most common reason for a physician’s visit and results in significant physical and psychosocial consequences in older adults.…
  • Abstract Number: 555 • 2018 ACR/ARHP Annual Meeting

    Three Year Outcomes of Patients with Elderly-Onset Rheumatoid Arthritis Treated with a Therapeutic Strategy Targeting Low Disease Activity, and Impact of Adverse Events on Physical Function

    Takahiko Sugihara1, Tatsuro Ishizaki2, Hiroyuki Baba3, Takumi Matsumoto3, Shoko Iga1, Takeshi Kusuda1, Marina Tsuchida1, Mari Kamiya3, Yoji Komiya3, Fumio Hirano4, Tadashi Hosoya3, Nobuyuki Miyasaka3 and Masayoshi Harigai5, 1Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 2Human Care Research Team, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan, 3Department of Medicine and Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan, 4Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Department of Rheumatology, Tokyo, Japan, 5Tokyo Women's Medical University, Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo, Japan

    Background/Purpose: The aim of this study was to evaluate three year outcomes of patients with elderly-onset RA (EORA) who were treated with a therapeutic strategy…
  • Abstract Number: 820 • 2018 ACR/ARHP Annual Meeting

    Incidence And Seasonal Variation Of Biopsy-Proven Giant Cell Arteritis – Revisited: A 20-Year Population-Based Study From Sweden

    Pavlos Stamatis1, Carl Turesson2, Jan-Åke Nilsson2 and Aladdin Mohammad3, 1Clinical Sciences, Rheumatology Lund, Lund University, Lund, Sweden, 2Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 3Rheumatology, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden

    Background/Purpose: To investigate the incidence rate and seasonal variation of biopsy-proven giant cell arteritis (GCA) in a well-defined population in southern Sweden. Methods: The study…
  • Abstract Number: 944 • 2018 ACR/ARHP Annual Meeting

    Gout: A Potential Risk Factor for Uveitis in the Older Adults?

    Jasvinder A. Singh and John Cleveland, Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Elevated intraocular levels of these pro-inflammatory cytokines and systemic levels of C-reactive protein are seen in uveitis, which leads to 30,000 new cases of…
  • Abstract Number: 1133 • 2018 ACR/ARHP Annual Meeting

    Factors for Opioids Use in the Early Treatment Options for the Knee Osteoarthritis Patients

    Soo-Kyung Cho1, Seongmi Choi2, Seul Gi Im2, Hyoungyoung Kim1, Sun-Young Jung3, Eun Jin Jang4 and Yoon-Kyoung Sung5, 1Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), 2Statistics, Kyungpook National University, Daegu, Korea, Republic of (South), 3College of Pharmacy, Chung-Ang University, Seoul, Korea, Republic of (South), 4Information Statistics, Andong National University, Andong-si, Korea, Republic of (South), 5Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South)

    Background/Purpose: Current guidelines for osteoarthritis (OA) treatment recommend a range of nonpharmacological and pharmacological interventions to alleviate pain, improve function and quality of life. Most…
  • Abstract Number: 1475 • 2018 ACR/ARHP Annual Meeting

    Eicosanoid Mediators of Systemic Inflammation and Arthritis in the Elderly

    Roxana Coras1,2, Rekha Narasimhan1, Arthur Kavanaugh3, Lourdes Mateo4, Oswald Quehenberger5, Melania Martinez-Morillo6 and Monica Guma1,2, 1Medicine, University of California San Diego, La Jolla, CA, 2Medicine, Autonomous University of Barcelona, Bellatera, Spain, 3University of California, San Diego, School of Medicine, La Jolla, CA, 4Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 5Pharmacology, Medicine, University of California San Diego, La Jolla, CA, 6Rheumatology, Germans Trias i Pujol University Hospital, Barcelona, Spain

    Background/Purpose: Elderly-onset RA, EORA, which is defined as rheumatoid arthritis (RA) starting at >60 years of age, has received less attention than young-onset RA. Polymyalgia rheumatica (PMR) is…
  • Abstract Number: 1543 • 2018 ACR/ARHP Annual Meeting

    The Efficacy, Safety and Adherence of Biologicbiological Disease-Modifying Anti Rheumatic Drugs, Infliximab, Tocilizumab and Abatacept, in Elderly Patients with Rheumatoid Arthritis

    Takuma Tsuzuki Wada1, Yu Funakubo Asanuma2, Mayumi Matsuda3, Hiroaki Yazawa2, Yoshinobu Nakao4, Noritsune Kozu5 and Toshihide Mimura2, 1Department of Rheumatology and Applied Immunology, Faculty of Medicine,, Saitama Medical University, Saitama, Japan, 2Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan, 3Department of Rheumatology and Applied Immunology, Saitama Medical University, Saitama, Japan, 4Department of Rheumatology, Saga University Hospital, Saga, Japan, 5Kozu Orthopedic Clinic, Yachiyo, Japan

    Background/Purpose: Elderly patients with rheumatoid arthritis (RA) have declined physical performances and increased various complications. We are concerned about decrease of efficacy and increase of…
  • Abstract Number: 2176 • 2018 ACR/ARHP Annual Meeting

    The Association of Gout with Incident Giant Cell Arteritis in Older Adults

    Jasvinder A. Singh and John Cleveland, Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Giant cell arteritis (GCA) is a vasculitis that affects large and medium sized arteries in people 50 years or older. Gout, the most common…
  • Abstract Number: 2226 • 2018 ACR/ARHP Annual Meeting

    Gout and the Risk of Incident Dementia in the Elderly: A Medicare Claims Study

    Jasvinder A. Singh1 and John Cleveland2, 1Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: The pursuit of a link between gout/hyperuricemia and dementia has led to contradictory results.  Most observational studies, including population-based studies, showed that hyperuricemia was…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences